HK1205764A1 - 結核病生物標誌物及其用途 - Google Patents
結核病生物標誌物及其用途Info
- Publication number
- HK1205764A1 HK1205764A1 HK15106261.2A HK15106261A HK1205764A1 HK 1205764 A1 HK1205764 A1 HK 1205764A1 HK 15106261 A HK15106261 A HK 15106261A HK 1205764 A1 HK1205764 A1 HK 1205764A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- tuberculosis biomarkers
- biomarkers
- tuberculosis
- Prior art date
Links
- 239000000090 biomarker Substances 0.000 title 1
- 201000008827 tuberculosis Diseases 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/5695—Mycobacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261623732P | 2012-04-13 | 2012-04-13 | |
PCT/US2013/036447 WO2013155460A1 (en) | 2012-04-13 | 2013-04-12 | Tuberculosis biomarkers and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1205764A1 true HK1205764A1 (zh) | 2015-12-24 |
Family
ID=49328218
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15106261.2A HK1205764A1 (zh) | 2012-04-13 | 2015-07-01 | 結核病生物標誌物及其用途 |
Country Status (6)
Country | Link |
---|---|
US (3) | US20140155411A1 (zh) |
EP (1) | EP2836608A4 (zh) |
JP (1) | JP2015514227A (zh) |
CA (1) | CA2867481A1 (zh) |
HK (1) | HK1205764A1 (zh) |
WO (1) | WO2013155460A1 (zh) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140155411A1 (en) | 2012-04-13 | 2014-06-05 | Somalogic, Inc. | Tuberculosis Biomarkers and Uses Thereof |
WO2015164616A1 (en) * | 2014-04-24 | 2015-10-29 | Somalogic, Inc. | Biomarkers for detection of tuberculosis |
WO2016182967A1 (en) * | 2015-05-08 | 2016-11-17 | Somalogic, Inc. | Biomarkers for detection of tuberculosis risk |
GB201519872D0 (en) | 2015-11-11 | 2015-12-23 | Univ Cape Town And Ct For Infectious Disease Res | Biomarkers for prospective determination of risk for development of active tuberculosis |
GB201602305D0 (en) * | 2016-02-09 | 2016-03-23 | Medical Res Council And Imp Innovations Ltd | TB Biomarkers |
EP3443356B1 (en) * | 2016-04-15 | 2024-06-05 | Stellenbosch University | Host biomarkers for immunodiagnosis and monitoring of tuberculosis disease |
US10607228B1 (en) * | 2016-08-24 | 2020-03-31 | Jpmorgan Chase Bank, N.A. | Dynamic rule strategy and fraud detection system and method |
JP2019537443A (ja) * | 2016-11-02 | 2019-12-26 | バイオイズ カンパニー リミテッド | 次世代配列決定法を用いた標的タンパク質の集団的定量方法とその用途 |
WO2018106481A1 (en) * | 2016-12-09 | 2018-06-14 | Basil Leaf Technologies, Llc | Computer-implemented methods, systems, and computer-readable media for diagnosing a condition |
JP6812789B2 (ja) * | 2016-12-28 | 2021-01-13 | 富士通株式会社 | 情報処理装置、情報処理プログラム、および情報処理方法 |
WO2019202448A1 (en) * | 2018-04-16 | 2019-10-24 | University Of Cape Town | A three-protein proteomic biomarker for prospective determination of risk for development of active tuberculosis |
JPWO2020162441A1 (zh) * | 2019-02-04 | 2020-08-13 | ||
BR112022006056A2 (pt) * | 2019-09-30 | 2022-07-12 | Univ Cape Town | Método para diagnosticar tuberculose em amostras de urina |
CN112034176B (zh) * | 2020-07-09 | 2022-08-30 | 中国工程物理研究院材料研究所 | Cntn1作为长期低剂量电离辐射暴露诊断的分子标记物的用途 |
US20220026417A1 (en) * | 2020-07-21 | 2022-01-27 | Industry-University Cooperation Foundation, Catholic University of Pusan | Method of simultaneously diagnosing active tuberculosis and latent tuberculosis infection using human whole blood sample-derived biomarker |
CN112481369A (zh) * | 2020-12-03 | 2021-03-12 | 中国医学科学院病原生物学研究所 | Msrb1作为结核病诊断分子标识的用途 |
US11676726B2 (en) * | 2021-06-22 | 2023-06-13 | David Haase | Apparatus and method for generating a treatment plan for salutogenesis |
WO2023021262A1 (en) * | 2021-08-17 | 2023-02-23 | Scotland's Rural College | Methods of determining animal phenotypes |
CN114250310B (zh) * | 2021-11-15 | 2023-12-08 | 四川大学华西医院 | 用于检测结核病的dna甲基化标志物、诊断模型、甲基化探针及试剂盒 |
CN115466797A (zh) * | 2022-06-06 | 2022-12-13 | 四川大学华西第二医院 | 用于检测rs4770965和rs9507713的试剂在制备结核筛查试剂盒中的用途 |
US20240229138A9 (en) * | 2022-10-24 | 2024-07-11 | Inflammatix, Inc. | Fluidic device and methods for characterization of an infection or other condition |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6143506A (en) * | 1998-08-13 | 2000-11-07 | The Research Foundation Of State Of Ny | Diagnostic method for detection of periodontitis or peri-implantitis |
WO2004001070A1 (en) * | 2002-06-20 | 2003-12-31 | Glaxo Group Limited | Surrogate markers for the determination of the disease status of an individual infected by mycobacterium tuberculosis |
US20060009378A1 (en) * | 2002-11-14 | 2006-01-12 | Itshak Golan | Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases |
DE602004026724D1 (de) * | 2003-06-13 | 2010-06-02 | Univ Pittsburgh | Überwachung von immunologischen, hämatologischen und entzündlichen erkrankungen |
GB0510511D0 (en) * | 2005-05-23 | 2005-06-29 | St Georges Entpr Ltd | Diagnosis of tuberculosis |
JP2007024631A (ja) | 2005-07-14 | 2007-02-01 | Human Science Shinko Zaidan | 同位体標識法 |
WO2007039489A1 (en) * | 2005-09-26 | 2007-04-12 | Apotech Corporation | Antibodies against april as biomarkers for early prognosis of lymphoma patients |
US20070292869A1 (en) * | 2006-03-02 | 2007-12-20 | Ppd Biomarker Discovery Sciences, Llc | Compositions and Methods for Analyzing Renal Cancer |
US20080085524A1 (en) * | 2006-08-15 | 2008-04-10 | Prometheus Laboratories Inc. | Methods for diagnosing irritable bowel syndrome |
KR100961926B1 (ko) * | 2007-08-30 | 2010-06-10 | 서울대학교산학협력단 | 당뇨병성 망막병증 검출용 바이오 마커 조성물 및 진단키트 |
AT505727B1 (de) * | 2007-09-04 | 2009-06-15 | Univ Innsbruck | Verfahren zur diagnose des metabolischen syndroms |
US20110129817A1 (en) * | 2009-11-30 | 2011-06-02 | Baylor Research Institute | Blood transcriptional signature of active versus latent mycobacterium tuberculosis infection |
TW201022492A (en) * | 2008-06-25 | 2010-06-16 | Baylor Res Inst | Blood transcriptional signature of mycobacterium tuberculosis infection |
ES2527455T3 (es) * | 2009-05-14 | 2015-01-23 | The Chancellor, Masters And Scholars Of The University Of Oxford | Diagnóstico clínico de fibrosis/cirrosis hepática usando biomarcadores de proteínas plasmáticas humanas poco abundantes |
BR112012024475A2 (pt) * | 2010-03-31 | 2015-09-15 | Firmenich & Cie | preparação de cápsulas sólidas que contêm aromas. |
US20110275794A1 (en) * | 2010-04-12 | 2011-11-10 | Somalogic, Inc. | 5-position modified pyrimidines and their use |
US20140155411A1 (en) | 2012-04-13 | 2014-06-05 | Somalogic, Inc. | Tuberculosis Biomarkers and Uses Thereof |
CN103065065A (zh) * | 2012-11-18 | 2013-04-24 | 浙江大学 | 一种活动性肺结核蛋白表达差异质谱模型及构建方法 |
-
2013
- 2013-04-12 US US13/862,177 patent/US20140155411A1/en not_active Abandoned
- 2013-04-12 CA CA2867481A patent/CA2867481A1/en not_active Abandoned
- 2013-04-12 EP EP13774934.7A patent/EP2836608A4/en not_active Withdrawn
- 2013-04-12 WO PCT/US2013/036447 patent/WO2013155460A1/en active Application Filing
- 2013-04-12 JP JP2015505956A patent/JP2015514227A/ja active Pending
-
2015
- 2015-07-01 HK HK15106261.2A patent/HK1205764A1/zh unknown
- 2015-12-14 US US14/968,276 patent/US20160109462A1/en not_active Abandoned
-
2017
- 2017-09-20 US US15/709,880 patent/US10408847B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CA2867481A1 (en) | 2013-10-17 |
US20180128839A1 (en) | 2018-05-10 |
US20160109462A1 (en) | 2016-04-21 |
WO2013155460A1 (en) | 2013-10-17 |
US10408847B2 (en) | 2019-09-10 |
EP2836608A1 (en) | 2015-02-18 |
JP2015514227A (ja) | 2015-05-18 |
EP2836608A4 (en) | 2016-02-24 |
US20140155411A1 (en) | 2014-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL269045B (en) | Aptamers and their uses | |
HK1205764A1 (zh) | 結核病生物標誌物及其用途 | |
HK1202545A1 (zh) | 新型二氮雜螺環烷烴和氮雜螺環烷烴 | |
HK1199023A1 (zh) | 取代的苯並噻吩基-吡咯並三嗪及其用途 | |
HK1218576A1 (zh) | 結核病生物標誌物及其用途 | |
HK1200822A1 (zh) | 取代的聯吡啶胺及其用途 | |
HK1208687A1 (zh) | 結合劑及其用途 | |
HK1210949A1 (zh) | 組合及其用途 | |
IL229844B (en) | Anti-psgl-1 antibodies and their use | |
EP2819749A4 (en) | BIOMARKERS ASSOCIATED WITH AUTISM AND USES THEREOF | |
ZA201400406B (en) | Trans-clomiphene metabolites and uses thereof | |
HK1210809A1 (zh) | β己糖基轉移酶及其用法 | |
GB201211158D0 (en) | Biomarkers and uses thereof | |
PL2882708T3 (pl) | Nowe związki i ich zastosowania | |
EP2693879A4 (en) | MIGRASTATINES AND THEIR USES | |
HK1203232A1 (zh) | 生物標誌物及其用途 | |
ZA201502159B (en) | Mycobacterial thiolperoxidase and its use | |
GB201218438D0 (en) | Biomarkers and uses thereof | |
GB201117881D0 (en) | Biomarkers and uses thereof | |
GB201222541D0 (en) | Kiddibidet and pottibidet | |
IL218974A0 (en) | Conaction bitwen coutch and playels | |
EP2922862A4 (en) | COMPLEX FORMING MODULATING ACTIVE SUBSTANCES AND USES THEREOF | |
GB201202021D0 (en) | Co-sleeper and breastfeeder | |
GB201205349D0 (en) | Bearing and bearing assembly | |
GB201203167D0 (en) | Bearing and bearing assembly |